2 results
Approved WMORecruiting
To assess safety and tolerability of AMX0035 for treatment of ALS.
Approved WMOPending
To prospectively investigate if a treatment strategy in which two types of cytotoxic RLT, i.e., an alpha-emitter and a beta-emitter, are alternatively offered to patients with oligometastatic HSPCa, is feasible and safe